L262-0892 Screening compound: 4-[6-(3,4-dimethoxyphenyl)pyrimidin-4-yl]-N-[(4-methoxyphenyl)methyl]piperazine-1-carboxamide

L262-0892 Screening compound: 4-[6-(3,4-dimethoxyphenyl)pyrimidin-4-yl]-N-[(4-methoxyphenyl)methyl]piperazine-1-carboxamide
L262-0892 Screening compound: 4-[6-(3,4-dimethoxyphenyl)pyrimidin-4-yl]-N-[(4-methoxyphenyl)methyl]piperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L262-0892
4-[6-(3,4-dimethoxyphenyl)pyrimidin-4-yl]-N-[(4-methoxyphenyl)methyl]piperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L262-0892

Molecular Formula

C25H29N5O4 (C25 H29 N5 O4)

Compound Name

4-[6-(3,4-dimethoxyphenyl)pyrimidin-4-yl]-N-[(4-methoxyphenyl)methyl]piperazine-1-carboxamide

IUPAC name

4-[6-(34-dimethoxyphenyl)pyrimidin-4-yl]-N-[(4-methoxyphenyl)methyl]piperazine-1-carboxamide

SMILES

COc1ccc(CNC(N(CC2)CCN2c2ncnc(-c(cc3)cc(OC)c3OC)c2)=O)cc1

InChI

InChI=1S/C25H29N5O4/c1-32-20-7-4-18(5-8-20)16-26-25(31)30-12-10-29(11-13-30)24-15-21(27-17-28-24)19-6-9-22(33-2)23(14-19)34-3/h4-9,14-15,17H,10-13,16H2,1-3H3,(H,26,31)

InChI Key

LGOLWVVGTAOFAN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27238787

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

463.54

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.475

Distribution Coefficient, logD

3.424

Water Solubility, LogSw

-3.64

Polar Surface Area

72.096

Acid Dissociation Constant (pKa)

15.52

Base Dissociation Constant (pKb)

6.50

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.00

L262-0892 in Drug Discovery

Included in Screening Libraries

Indoleamine 2,3-dioxygenase 1 Focused Library (5816 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Immune system
Targets:
  • Others

References: we are preparing a list of scientific research reports with L262-0892 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L262-0892?
Check Price and Availability of L262-0892, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L262-0892 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L262-0892
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L262-0892
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L262-0892 available by request